The global Apatinib market size was valued at US$ 456 million in 2024 and is projected to reach US$ 790.4 million by 2030, at a CAGR of 9.6% during the forecast period 2024-2030.
United States Apatinib market size was valued at US$ 148 million in 2024 and is projected to reach US$ 248 million by 2030, at a CAGR of 9.0% during the forecast period 2024-2030.
A small molecule tyrosine kinase inhibitor that selectively inhibits VEGFR-2.
Rapid growth supported by expanding indications in various cancer types. Strong market presence in China with potential for global expansion. Ongoing clinical trials for combination therapies in multiple cancer indications.
Report Overview
This report provides a deep insight into the global Apatinib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Apatinib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Apatinib market in any manner.
Global Apatinib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Advenchen Laboratories
- Jiangsu Hengrui Medicine
- LSK BioPartners
- Bukwang Pharmaceutical Company
Market Segmentation (by Type)
- 0.25g/Pcs
- 0.425g/Pcs
- 0.375g/Pcs
Market Segmentation (by Application)
- Metastatic Gastric Carcinoma
- Metastatic Breast Cancer
- Advanced Hepatocellular Carcinoma
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Apatinib Market
- Overview of the regional outlook of the Apatinib Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Apatinib
1.2 Key Market Segments
1.2.1 Apatinib Segment by Type
1.2.2 Apatinib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Apatinib Market Overview
2.1 Global Market Overview
2.1.1 Global Apatinib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Apatinib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Apatinib Market Competitive Landscape
3.1 Global Apatinib Sales by Manufacturers (2019-2024)
3.2 Global Apatinib Revenue Market Share by Manufacturers (2019-2024)
3.3 Apatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Apatinib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Apatinib Sales Sites, Area Served, Product Type
3.6 Apatinib Market Competitive Situation and Trends
3.6.1 Apatinib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Apatinib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Apatinib Industry Chain Analysis
4.1 Apatinib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Apatinib Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Apatinib Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Apatinib Sales Market Share by Type (2019-2024)
6.3 Global Apatinib Market Size Market Share by Type (2019-2024)
6.4 Global Apatinib Price by Type (2019-2024)
7 Apatinib Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Apatinib Market Sales by Application (2019-2024)
7.3 Global Apatinib Market Size (M USD) by Application (2019-2024)
7.4 Global Apatinib Sales Growth Rate by Application (2019-2024)
8 Apatinib Market Segmentation by Region
8.1 Global Apatinib Sales by Region
8.1.1 Global Apatinib Sales by Region
8.1.2 Global Apatinib Sales Market Share by Region
8.2 North America
8.2.1 North America Apatinib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Apatinib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Apatinib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Apatinib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Apatinib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Advenchen Laboratories
9.1.1 Advenchen Laboratories Apatinib Basic Information
9.1.2 Advenchen Laboratories Apatinib Product Overview
9.1.3 Advenchen Laboratories Apatinib Product Market Performance
9.1.4 Advenchen Laboratories Business Overview
9.1.5 Advenchen Laboratories Apatinib SWOT Analysis
9.1.6 Advenchen Laboratories Recent Developments
9.2 Jiangsu Hengrui Medicine
9.2.1 Jiangsu Hengrui Medicine Apatinib Basic Information
9.2.2 Jiangsu Hengrui Medicine Apatinib Product Overview
9.2.3 Jiangsu Hengrui Medicine Apatinib Product Market Performance
9.2.4 Jiangsu Hengrui Medicine Business Overview
9.2.5 Jiangsu Hengrui Medicine Apatinib SWOT Analysis
9.2.6 Jiangsu Hengrui Medicine Recent Developments
9.3 LSK BioPartners
9.3.1 LSK BioPartners Apatinib Basic Information
9.3.2 LSK BioPartners Apatinib Product Overview
9.3.3 LSK BioPartners Apatinib Product Market Performance
9.3.4 LSK BioPartners Apatinib SWOT Analysis
9.3.5 LSK BioPartners Business Overview
9.3.6 LSK BioPartners Recent Developments
9.4 Bukwang Pharmaceutical Company
9.4.1 Bukwang Pharmaceutical Company Apatinib Basic Information
9.4.2 Bukwang Pharmaceutical Company Apatinib Product Overview
9.4.3 Bukwang Pharmaceutical Company Apatinib Product Market Performance
9.4.4 Bukwang Pharmaceutical Company Business Overview
9.4.5 Bukwang Pharmaceutical Company Recent Developments
10 Apatinib Market Forecast by Region
10.1 Global Apatinib Market Size Forecast
10.2 Global Apatinib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Apatinib Market Size Forecast by Country
10.2.3 Asia Pacific Apatinib Market Size Forecast by Region
10.2.4 South America Apatinib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Apatinib by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Apatinib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Apatinib by Type (2025-2030)
11.1.2 Global Apatinib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Apatinib by Type (2025-2030)
11.2 Global Apatinib Market Forecast by Application (2025-2030)
11.2.1 Global Apatinib Sales (Kilotons) Forecast by Application
11.2.2 Global Apatinib Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Apatinib Market Size Comparison by Region (M USD)
Table 5. Global Apatinib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Apatinib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Apatinib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Apatinib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apatinib as of 2022)
Table 10. Global Market Apatinib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Apatinib Sales Sites and Area Served
Table 12. Manufacturers Apatinib Product Type
Table 13. Global Apatinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Apatinib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Apatinib Market Challenges
Table 22. Global Apatinib Sales by Type (Kilotons)
Table 23. Global Apatinib Market Size by Type (M USD)
Table 24. Global Apatinib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Apatinib Sales Market Share by Type (2019-2024)
Table 26. Global Apatinib Market Size (M USD) by Type (2019-2024)
Table 27. Global Apatinib Market Size Share by Type (2019-2024)
Table 28. Global Apatinib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Apatinib Sales (Kilotons) by Application
Table 30. Global Apatinib Market Size by Application
Table 31. Global Apatinib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Apatinib Sales Market Share by Application (2019-2024)
Table 33. Global Apatinib Sales by Application (2019-2024) & (M USD)
Table 34. Global Apatinib Market Share by Application (2019-2024)
Table 35. Global Apatinib Sales Growth Rate by Application (2019-2024)
Table 36. Global Apatinib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Apatinib Sales Market Share by Region (2019-2024)
Table 38. North America Apatinib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Apatinib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Apatinib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Apatinib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Apatinib Sales by Region (2019-2024) & (Kilotons)
Table 43. Advenchen Laboratories Apatinib Basic Information
Table 44. Advenchen Laboratories Apatinib Product Overview
Table 45. Advenchen Laboratories Apatinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Advenchen Laboratories Business Overview
Table 47. Advenchen Laboratories Apatinib SWOT Analysis
Table 48. Advenchen Laboratories Recent Developments
Table 49. Jiangsu Hengrui Medicine Apatinib Basic Information
Table 50. Jiangsu Hengrui Medicine Apatinib Product Overview
Table 51. Jiangsu Hengrui Medicine Apatinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Jiangsu Hengrui Medicine Business Overview
Table 53. Jiangsu Hengrui Medicine Apatinib SWOT Analysis
Table 54. Jiangsu Hengrui Medicine Recent Developments
Table 55. LSK BioPartners Apatinib Basic Information
Table 56. LSK BioPartners Apatinib Product Overview
Table 57. LSK BioPartners Apatinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. LSK BioPartners Apatinib SWOT Analysis
Table 59. LSK BioPartners Business Overview
Table 60. LSK BioPartners Recent Developments
Table 61. Bukwang Pharmaceutical Company Apatinib Basic Information
Table 62. Bukwang Pharmaceutical Company Apatinib Product Overview
Table 63. Bukwang Pharmaceutical Company Apatinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bukwang Pharmaceutical Company Business Overview
Table 65. Bukwang Pharmaceutical Company Recent Developments
Table 66. Global Apatinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 67. Global Apatinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America Apatinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 69. North America Apatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe Apatinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 71. Europe Apatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific Apatinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 73. Asia Pacific Apatinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America Apatinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 75. South America Apatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa Apatinib Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa Apatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global Apatinib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 79. Global Apatinib Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global Apatinib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 81. Global Apatinib Sales (Kilotons) Forecast by Application (2025-2030)
Table 82. Global Apatinib Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Apatinib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Apatinib Market Size (M USD), 2019-2030
Figure 5. Global Apatinib Market Size (M USD) (2019-2030)
Figure 6. Global Apatinib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Apatinib Market Size by Country (M USD)
Figure 11. Apatinib Sales Share by Manufacturers in 2023
Figure 12. Global Apatinib Revenue Share by Manufacturers in 2023
Figure 13. Apatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Apatinib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Apatinib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Apatinib Market Share by Type
Figure 18. Sales Market Share of Apatinib by Type (2019-2024)
Figure 19. Sales Market Share of Apatinib by Type in 2023
Figure 20. Market Size Share of Apatinib by Type (2019-2024)
Figure 21. Market Size Market Share of Apatinib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Apatinib Market Share by Application
Figure 24. Global Apatinib Sales Market Share by Application (2019-2024)
Figure 25. Global Apatinib Sales Market Share by Application in 2023
Figure 26. Global Apatinib Market Share by Application (2019-2024)
Figure 27. Global Apatinib Market Share by Application in 2023
Figure 28. Global Apatinib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Apatinib Sales Market Share by Region (2019-2024)
Figure 30. North America Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Apatinib Sales Market Share by Country in 2023
Figure 32. U.S. Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Apatinib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Apatinib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Apatinib Sales Market Share by Country in 2023
Figure 37. Germany Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Apatinib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Apatinib Sales Market Share by Region in 2023
Figure 44. China Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Apatinib Sales and Growth Rate (Kilotons)
Figure 50. South America Apatinib Sales Market Share by Country in 2023
Figure 51. Brazil Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Apatinib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Apatinib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Apatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Apatinib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Apatinib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Apatinib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Apatinib Market Share Forecast by Type (2025-2030)
Figure 65. Global Apatinib Sales Forecast by Application (2025-2030)
Figure 66. Global Apatinib Market Share Forecast by Application (2025-2030)
